-
HDAMM-predictor: prediction of progression in asymptomatic myeloma patients
The HDAMM-predictor is based on microarray gene expression and predicts the risk of progression from asymptomatic to symptomatic myeloma. It divides the patients in three... -
HDAMM-predictor: prediction of progression in asymptomatic myeloma patients
The HDAMM-predictor is based on microarray gene expression and predicts the risk of progression from asymptomatic to symptomatic myeloma. It divides the patients in three...
